Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease

NCT07284784 is registered in ClinicalTrials.gov with Annovis Bio Inc. as lead sponsor.

NCT NCT07284784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07284784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Parkinson's Disease
Lead sponsor
Annovis Bio Inc.
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 9, 2026
Completion date
November 30, 2029
Enrollment
500 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

deep brain stimulation, parkinson's disease (pd)